One of the hottest health care-related hedge funds is planning to launch its second blank-check company one month after its first one closed on a merger deal.
EcoR1 Capital, headed by one-time Institutional Investor Hedge Fund Rising Star Oleg Nodelman, on Tuesday said in a regulatory filing that it is seeking to raise at least $150 million for Panacea Acquisition Corp.